$STEM

Stem's PowerTrack EMS Enables Hybridization Of Two Operating Utility-Scale Solar Plants In Hungary

Stem, Inc. (NYSE: STEM) said Solarmarkt Group and EPC partner Pannonwatt selected Stem’s PowerTrack Energy Management System for hybridizing two operating utility solar plants in Hungary. Each 60 MWp site will add 40 MW/80 MWh batteries, with commercial operation expected by Sept 2026 under a five-year agreement.

Original reporting
Published Aug 18, 2026, 1:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 18, 2026, 1:23 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefTechnology
Primary signal
$STEM
Bullish
medium confidence
Mentioned
$STEM
Relevance
6/10
AlphAI data visualization · based on poweronline.com
Decision brief

The 30-second read

$STEMBullishMed
01

Why it matters

The announcement signals continued European traction for Stem’s software and managed services tied to battery hybridization, with a stated initial focus on Hungary’s aFRR market and a roadmap toward FCR and cross-border value stacking.

02

Market read

A new five-year EMS platform expansion for operating solar sites retrofitted with storage, with a clear operational target date and reserve-market use case.

03

What to watch

Execution risk remains (localized grid compliance, reserve-market qualification, and battery commissioning). Also, revenue recognition timing may lag the Sept 2026 operational milestone.

Relevance 6/10Novelty 7/10Timing: today’s PR on a new five-year EMS agreement, with commercial operation expected by Sept 2026

Background

Stem’s PowerTrack EMS is positioned as a hybrid-ready control and monitoring platform that can extend existing solar PPC/SCADA foundations across added battery systems.

Company-level read

Ticker impact

$STEMBullishMedium confidence
Context

Stem selected for a five-year PowerTrack EMS deal to hybridize two 60 MWp solar plants in Hungary with 40 MW/80 MWh batteries each, targeting Sept 2026 commercial ops.

Expected impact

Moderate positive bias for STEM on deal-quality and execution credibility, but likely limited near-term impact without disclosed financial terms.

Evidence & confidence

The article is a fresh contract announcement with clear scope (EMS, PPC, SCADA) and timeline (Sept 2026), but it provides no contract value, customer financials, or incremental guidance, limiting magnitude.

Market effects

Reinforces demand for hybrid solar-plus-storage control software and SCADA/PPC integration in Europe’s ancillary-services markets.

Highlights Central and Eastern Europe grid-integration and reserve-market participation (aFRR) as a near-term monetization pathway for hybrid assets.

Supports the broader thesis that operating renewables are being retrofitted with storage using unified digital control stacks.

Counterpoint

Without disclosed contract value or performance KPIs, the market may treat this as incremental rather than material, especially if similar EMS wins are already priced in.

Key entities

  • Stem, Inc.

    NYSE-listed clean energy software and services provider selected to supply PowerTrack EMS for hybridization of two Hungarian solar plants.

  • Solarmarkt Group

    Hungary-based renewable energy company adding 40 MW/80 MWh batteries to two existing 60 MWp solar facilities.

  • Pannonwatt Energetikai Megoldások Zrt.

    Hungarian EPC partner supporting grid integration and execution for the hybrid projects.

Related articles

$STEMMed

Stem, Inc.: Stem's PowerTrack EMS Enables Hybridization of Two Operating Utility-Scale Solar Plants in Hungary

Stem, Inc. (NYSE: STEM) said Solarmarkt Group, with EPC partner Pannonwatt, selected Stem’s PowerTrack Energy Management System to hybridize two operating utility-scale solar plants in Hungary. The five-year agreement covers adding 40 MW/80 MWh batteries to each site, targeting commercial operation by Sept 2026 and participation in Hungary’s aFRR market.

$STEMMed

STEM, INC. (STEM): Completion of Acquisition or Disposition of Assets

STEM, INC. (STEM) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. Exhibit 99 Stem Announces Second Quarter 2026 Results Achieved fifth consecutive quarter of positive adjusted EBITDA PowerTrack TM software revenue up 11% YoY PowerTrack TM Energy Management System (EMS) recognized as leading, global innovative solution with The smarter E AWARD w

$PSKYMed

Why Did PSKY, UBER, STEM Stocks Plummet To 52-Week Lows?

Stocks of Paramount Skydance (PSKY), Uber (UBER) and Stem (STEM) hit 52-week lows. PSKY fell after delaying its Warner Bros. Discovery merger to June 1, 2027 amid a multistate antitrust suit. UBER dropped on slower growth and Waymo partnership concerns. STEM slid on EV charging weakness and Barclays cut its price target to $8; revenue fell 11% to $29M.

$VMedAI 8/10

Visa And Mesh Let Crypto Wallet Users Spend Stablecoin Balances At 175 Million Merchants: 16 outlets compared

Visa and Mesh partnered to enable spending of crypto and stablecoin balances at 175M+ merchants via Visa's network. Mesh handles funding and conversion, while merchants receive payments through Visa's existing infrastructure. No launch date or supported cryptocurrencies were disclosed. Visa reported $20B annualized stablecoin settlement activity in September. Mesh, a unicorn with $75M in Series C funding, manages the program.

$CYDYMedAI 8/10

CytoDyn Highlights Early CLOVER Data, Names Robert Hoffman CEO

CytoDyn reported early CLOVER study data, showing an average 93% ctDNA decrease in 12 patients. The company plans to present updated data at upcoming medical conferences. CytoDyn also named Robert Hoffman as CEO and expects cash to fund operations into mid-2027. The company is pursuing regulatory paths for leronlimab, including Fast Track and Breakthrough Therapy designations, and is exploring additional cancer studies. CytoDyn had $18.3 million in cash as of August 31, 2024.